1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2        North America Overactive Bladder Treatment Market– By Disease Type

1.3.3        North America Overactive Bladder Treatment Market – By Country

2.           North America Overactive Bladder Treatment Market Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Overactive Bladder Treatment Market Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Overactive Bladder Treatment Market Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Urinary Incontinence

5.1.2        Growing Incidence of Urinary Tract Infections

5.2         Key Market Restraints

5.2.1        Recalls of Therapeutic Drugs

5.3         Key Market Opportunities

5.3.1        Increasing Number of Mergers and Acquisitions

5.4         Future Trends

5.4.1        Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5         Impact analysis

6.           North America Overactive Bladder Treatment Market – North America Analysis

6.1         North America Overactive Bladder Treatment Market Revenue Forecast and Analysis

7.           North America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1         Overview

7.2         North America Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3         Mirabegron

7.3.1        Overview

7.3.2        Mirabegron: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4         Botox

7.4.1        Overview

7.4.2        Botox: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5         Neurostimulation

7.5.1        Overview

7.5.2        Neurostimulation: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3        Transcutaneous Sacral Nerve Stimulation

7.5.3.1          Overview

7.5.3.2          Transcutaneous Sacral Nerve Stimulation: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4        Transcutaneous Tibial Nerve Stimulation

7.5.4.1          Overview

7.5.4.2          Transcutaneous Tibial Nerve Stimulation: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5        Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1          Overview

7.5.5.2          Percutaneous Posterior Tibial Nerve Stimulation: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6        Others

7.5.6.1          Overview

7.5.6.2          Others: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Anticholinergics

7.6.1        Overview

7.6.2        Anticholinergics: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3        Solifenacin

7.6.3.1          Overview

7.6.3.2          Solifenacin: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4        Oxybutynin

7.6.4.1          Overview

7.6.4.2          Oxybutynin: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5        Fesoterodine

7.6.5.1          Overview

7.6.5.2          Fesoterodine: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6        Darifenacin

7.6.6.1          Overview

7.6.6.2          Darifenacin: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7        Tolterodine

7.6.7.1          Overview

7.6.7.2          Tolterodine: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8        Trospium

7.6.8.1          Overview

7.6.8.2          Trospium: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9        Other Anticholinergics

7.6.9.1          Overview

7.6.9.2          Other Anticholinergics: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7         Intravesical Instillation

7.7.1        Overview

7.7.2        Intravesical Instillation: North America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.           North America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1         Overview

8.2         North America Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3         Idiopathic Overactive Bladder

8.3.1        Overview

8.3.2        Idiopathic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Neurogenic Overactive Bladder

8.4.1        Overview

8.4.2        Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9.           Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

9.1         Overview

9.1.2        North America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.2.1          US: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.1          US: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2          US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2.1       US: Overactive Bladder Treatment Market, by Anticholinergics– Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2.2       US: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.3          US: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.1.2.2          Canada: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.1          Canada: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2          Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2.1       Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2.2       Canada: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.3          Canada: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

9.1.2.3          Mexico: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.1          Mexico: Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2          Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2.1       Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2.2       Mexico: Overactive Bladder Treatment Market, by Neurostimulation– Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.3          Mexico: Overactive Bladder Treatment Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)

10.        Overactive Bladder Treatment Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

11.        Company Profiles

11.1      Alembic Pharmaceuticals Limited

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Astellas Pharma Inc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      AbbVie Inc

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Teva Pharmaceutical Industries Ltd

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Endo Pharmaceuticals Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Hisamitsu Pharmaceutical Co.,Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Medtronic Plc

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Colorado Urology Associates, PLLC

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Axonics Modulation Technologies, Inc

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Pfizer Inc

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Overactive Bladder Treatment Market Segmentation

Figure 2.           North America Overactive Bladder Treatment Market Segmentation, By Country

Figure 3.           North America Overactive Bladder Treatment Market Overview

Figure 4.           Mirabegron Segment Held Largest Share by Pharmacotherapy in North America Overactive Bladder Treatment market

Figure 5.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7.           North America: PEST Analysis

Figure 8.           North America Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 9.           North America Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10.        North America Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 11.        Mirabegron: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Botox: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Neurostimulation: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Transcutaneous Sacral Nerve Stimulation: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Transcutaneous Tibial Nerve Stimulation: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 16.        Percutaneous Posterior Tibial Nerve: North America Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17.        Others: North America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18.        Anticholinergics: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Solifenacin: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Oxybutynin: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Fesoterodine: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Darifenacin: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Tolterodine: North America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Trospium: North America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Other Anticholinergics: North America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Intravesical Instillation: North America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        North America Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 28.        Idiopathic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        North America: Overactive Bladder Treatment Market Revenue Overview, By Key Country – Revenue (2021) (US$ Million)

Figure 31.        North America: Overactive Bladder Treatment Market, By Country, 2021 & 2028 (%)

Figure 32.        US: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 33.        Canada: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)

Figure 34.        Mexico: Overactive Bladder Treatment Market Revenue and Forecast To 2028 (US$ Million)